Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 482
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07764783 VISION — Visual Instillation of Sphenopalatine-block Intervention for O… |
Topical solution of 4% lidocaine | Migraine | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Association of Migraine Disorders | United States · Ear, Nose, & Throat Surgeons of Weste… | 2027-01 → 2029-01 | Ouvrir |
| NCT06462781 LIGHT 1 — Localized Injection of Lidocaine and Glucocorticoid for Heada… |
Lidocaine Hydrochloride | Migraine | Phase 1 | COMPLETED | En attente / non publié | Cooper Norcross Health | United States · Cooper University Health Care, Camden… | 2024-03-15 → 2025-06-01 | Ouvrir |
| NCT07916571 Migraine Menopause Study |
Eptinezumab 100 mg or Eptinezumab… | Migraine | Phase 4 | NOT_YET_RECRUITING | En attente / non publié | Alberta Neurologic Centre | Non communiqué | 2027-02-01 → 2028-04-30 | Ouvrir |
| NCT05477095 A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicit… |
UB-313 | Migraine | Phase 1 | COMPLETED | En attente / non publié | Axxium Life, Inc. | Belgium · Katholieke Universiteit Leuven, Leuven, Bel… | 2022-07-06 → 2023-10-06 | Ouvrir |
| NCT07816367 A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the … |
Elismetrep | Migraine | Phase 3 | RECRUITING | En attente / non publié | TriGemX Bio, Inc. | United States · Accellacare - Cary (Cary Medical Grou… | 2026-10-02 → 2027-12 | Ouvrir |
| NCT07645924 A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in th… |
Elismetrep | Migraine | Phase 3 | RECRUITING | En attente / non publié | TriGemX Bio, Inc. | United States · Access Clinical Trials, Inc, Nashvill… | 2026-07-01 → 2027-02 | Ouvrir |
| NCT07616128 Study of EVO756 in Adults With Migraine |
EVO756, Dose 1 | Migraine | Phase 2 | RECRUITING | En attente / non publié | Evommune, Inc. | United States, Australia, Canada, New Zealand · Accel… | 2026-07-29 → 2027-11 | Ouvrir |
| NCT07674654 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment o… |
Elismetrep | Migraine | Phase 3 | RECRUITING | En attente / non publié | TriGemX Bio, Inc. | United States · Access Clinical Trials Inc, Nashville… | 2026-08-03 → 2028-06 | Ouvrir |
| NCT06735833 MMA Embolization for Refractory Chronic Migraine |
Middle Meningeal Artery embolizat… | Migraine | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | The Affiliated Hospital Of Guizho… | United States · Barrow Neurological Institute at St. … | 2025-04-23 → 2029-07-31 | Ouvrir |
| NCT07116499 A Study of K-645 in the Treatment of Multiple Migraine Attacks |
K-645 100 mg | Migraine | Phase 2 | TERMINATED | En attente / non publié | TriGemX Bio, Inc. | United States · Albuquerque Clinical Trials, Inc., Al… | 2025-08-13 → 2025-11-18 | Ouvrir |
| NCT07918053 NIGHTCAP — A Prospective Study of Rimegepant for Short-term Preventive … |
Rimegepant 75 mg ODT | Migraine | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Chinese PLA General Hospital | China · Chinese People's Liberation Army General Hosp… | 2026-12 → 2027-08 | Ouvrir |
| NCT06468189 MIRAGE — Clinical and Neurophysiological Effects of tDCS to Visual and … |
transcranial direct stimulation | Migraine | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Istanbul Medipol University Hospi… | Turkey (Türkiye) · İstanbul Medipol University, Istan… | 2024-03-01 → 2027-11 | Ouvrir |
| NCT05907655 Study of the Glymphatic System in Migraine |
Nitroglycerin 0.3 MG | Migraine | À vérifier | RECRUITING | En attente / non publié | IRCCS San Raffaele | Italy · IRCCS San Raffaele Hospital, Milan, Italy | 2023-04-30 → 2027-04-04 | Ouvrir |
| NCT07903168 Epi-IRIS — Why Do People With Epilepsy Get More Infections? |
Antiepileptic Drug | Épilepsie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | University of Aberdeen | Institute of Applied Health Sciences, University of A… | 2026-11 → 2038-05 | Ouvrir |
| NCT04384367 RELIEF — Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the… |
Rizatriptan 10 mg + Naproxen 550mg | Migraine | Phase 3 | COMPLETED | En attente / non publié | Eurofarma Laboratorios S.A. | Brazil · CEPIC, São Paulo, Brazil | Eurofarma Laborat… | 2022-12-30 → 2024-11-30 | Ouvrir |
| NCT06799169 Management of Acute Tinnitus With Migraine Medications |
Nortriptyline | Migraine | Phase 4 | SUSPENDED | En attente / non publié | University of California, Irvine | United States · University of California, Irvine Medi… | 2025-06-01 → 2030-12 | Ouvrir |
| NCT07667621 A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants… |
Rimegepant | Migraine | Phase 1 | RECRUITING | En attente / non publié | University of South Florida | United States · Tampa General Hospital Emergency Room… | 2026-09-15 → 2027-08 | Ouvrir |
| NCT07279623 A-MI-01 — Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Pr… |
INMEST-treatment | Migraine | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Abilion Medical Systems AB | Sweden · INMEST-mottagningen Odenplan, Stockholm, Swe… | 2025-10-21 → 2026-11 | Ouvrir |
| NCT07313800 EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Em… |
TEMMA Endovascular Treatment | Migraine | Non applicable | WITHDRAWN | En attente / non publié | Cortex Neurovascular | United States · Cortex Neurovascular / TRA Union, Tac… | 2028-03-01 → 2032-03-01 | Ouvrir |
| NCT06602479 AURORA — A Study to Investigate the Safety and Efficacy of MEDI0618 Com… |
MEDI0618 | Migraine | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | AbbVie | United States, Czechia, Denmark, Germany, Hungary, It… | 2024-10-07 → 2027-02 | Ouvrir |
| NCT06898047 CORRELATE-UK — Consistency of Response With Rimegepant in Acute Treatme… |
Rimegepant for acute migraine tre… | Migraine | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | Pfizer | United Kingdom · Pfizer, London, United Kingdom | 2025-11-15 → 2026-10-31 | Ouvrir |
| NCT07906262 Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bay… |
Rimegepant | Migraine | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | University of South Florida | United States · Pfizer, New York, United States | 2026-10-12 → 2026-12-31 | Ouvrir |
| NCT07191145 Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Head… |
Eptinezumab | Migraine | Phase 3 | RECRUITING | En attente / non publié | H. Lundbeck A/S | Canada · Sunnybrook Health Sciences Centre, Toronto, … | 2026-11 → 2027-12-30 | Ouvrir |
| NCT06212661 Migraine Medication Effects on Urinary Symptoms |
Ubrogepant | Migraine | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | AbbVie | United States · Cleveland Clinic, Main Campus, Clevel… | 2024-04-05 → 2027-12 | Ouvrir |
| NCT03263897 Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse In… |
insufflation | Migraine | Non applicable | TERMINATED | En attente / non publié | Caps Research Network | United States · FNOR Clinic Scottsdale, Scottsdale, U… | 2017-08-21 → 2020-12-31 | Ouvrir |